| 25 May 2026 |
Abaloparatide |
7.1 |
5mg |
6.2mg |
+23.7% |
97.58% |
Lab A |
| 25 May 2026 |
AHK-CU |
9.7 |
20mg |
21.0mg |
+5.2% |
95.76% |
Lab D |
| 25 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
6.0 |
10mg |
9.2mg |
-8.4% |
97.17% |
Lab C |
| 25 May 2026 |
PEG MGF |
6.4 |
10mg |
11.8mg |
+18.4% |
99.22% |
Lab C |
| 24 May 2026 |
Selank 10mg + Semax 10mg Blend |
7.6 |
5mg |
4.3mg |
-14.5% |
98.56% |
Lab B |
| 24 May 2026 |
Prednisone |
5.9 |
50mg |
43.3mg |
-13.4% |
95.55% |
Lab D |
| 24 May 2026 |
Alprostadil |
4.3 |
10mg |
10.2mg |
+2.4% |
98.24% |
Lab D |
| 24 May 2026 |
CJC-1295 With DAC |
10.0 |
50mg |
43.5mg |
-13.0% |
95.01% |
Lab F |
| 24 May 2026 |
SNAP-8 |
4.0 |
20mg |
24.8mg |
+24.0% |
99.84% |
Lab E |
| 23 May 2026 |
P21 |
7.8 |
15mg |
15.0mg |
-0.0% |
96.43% |
Lab A |
| 23 May 2026 |
SS-31 (Elamipretide) Raw |
10.0 |
500g |
497.7g |
-0.5% |
96.45% |
Lab E |
| 23 May 2026 |
Bronchogen |
7.7 |
20mg |
24.7mg |
+23.7% |
96.38% |
Lab D |
| 21 May 2026 |
BPC 500mcg + TB500 500mcg Blend Oral |
10.0 |
25mg |
29.1mg |
+16.5% |
95.39% |
Lab F |
| 21 May 2026 |
Retatrutide 30mg Pen Kit |
5.3 |
20mg |
18.5mg |
-7.7% |
97.08% |
Lab B |
| 21 May 2026 |
Turinabol |
6.2 |
50mg |
55.1mg |
+10.2% |
96.51% |
Lab B |
| 21 May 2026 |
Dianabol |
9.7 |
100mg |
122.9mg |
+22.9% |
95.40% |
Lab A |
| 20 May 2026 |
Sustanon 400 |
6.6 |
100mg/ml |
122.3mg/ml |
+22.3% |
97.16% |
Lab C |
| 19 May 2026 |
Clomiphene (Clomid) Raw |
9.7 |
10g |
11.9g |
+18.9% |
96.63% |
Lab C |
| 19 May 2026 |
GHRP-6 Acetate |
7.6 |
30mg |
31.4mg |
+4.6% |
99.54% |
Lab A |
| 19 May 2026 |
T3 (Liothyronine) |
6.7 |
25mg |
28.9mg |
+15.8% |
96.33% |
Lab D |
| 29 Jan 2026 |
Semax |
7.3 |
2mg |
2.4mg |
+17.6% |
95.47% |
Lab D |
| 19 Jan 2026 |
Liraglutide |
8.2 |
30mg |
32.9mg |
+9.8% |
97.85% |
Lab C |
| 19 Jan 2026 |
Primobolan E |
7.6 |
250mg/ml |
217.2mg/ml |
-13.1% |
98.19% |
Lab A |
| 9 Jan 2026 |
Equipoise (Boldenone Undecylenate) |
4.4 |
200mg/ml |
247.2mg/ml |
+23.6% |
99.03% |
Lab C |
| 9 Jan 2026 |
MGF |
7.7 |
20mg |
20.8mg |
+3.8% |
98.68% |
Lab D |
| 7 Jan 2026 |
LGD-4033 (Ligandrol) Raw |
5.0 |
1g |
0.9g |
-5.9% |
96.99% |
Lab D |
| 6 Jan 2026 |
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 |
8.7 |
10g |
8.9g |
-11.3% |
95.47% |
Lab G |
| 12 Dec 2025 |
DNP |
5.0 |
25mg |
26.7mg |
+6.7% |
96.53% |
Lab F |
| 5 Dec 2025 |
Ivermectin |
4.4 |
25mg |
29.2mg |
+16.7% |
99.12% |
Lab F |
| 17 Nov 2025 |
Retatrutide 5mg + Cagrilintide 5mg Blend |
6.9 |
2mg |
1.8mg |
-9.6% |
96.29% |
Lab E |
| 5 Nov 2025 |
ACE-031 |
8.4 |
10mg |
8.8mg |
-11.9% |
97.78% |
Lab G |
| 5 Nov 2025 |
Chonluten |
9.1 |
20mg |
19.7mg |
-1.7% |
97.44% |
Lab D |
| 5 Nov 2025 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
10.0 |
2mg |
1.8mg |
-11.0% |
96.28% |
Lab F |
| 4 Nov 2025 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
7.4 |
50mg |
57.5mg |
+15.0% |
95.43% |
Lab C |
| 4 Nov 2025 |
IGF-1 LR3 |
9.1 |
15mg |
17.1mg |
+14.2% |
98.96% |
Lab B |
| 17 Oct 2025 |
Tirzepatide |
7.4 |
30mg |
32mg |
+6.7% |
99.95% |
Lab E |
| 17 Oct 2025 |
Tirzepatide |
7.9 |
10mg |
9.87mg |
-1.3% |
99.86% |
Lab E |
| 17 Oct 2025 |
EPO |
10.0 |
20mg |
24.8mg |
+23.9% |
95.90% |
Lab F |
| 9 Oct 2025 |
BMK ethyl glycidate CAS 41232-97-7 |
6.6 |
100g |
88.0g |
-12.0% |
97.85% |
Lab A |
| 3 Oct 2025 |
Botulinum toxin |
8.9 |
20mg |
18.6mg |
-7.1% |
95.94% |
Lab E |
| 3 Oct 2025 |
Oxytocin Acetate |
6.5 |
10mg |
10.4mg |
+4.3% |
96.79% |
Lab A |
| 3 Oct 2025 |
SLU-PP-332 250mcg + BAM15 50mcg Blend |
9.9 |
100mg |
93.8mg |
-6.2% |
97.67% |
Lab D |
| 25 Jul 2025 |
Tirzepatide |
8.0 |
30mg |
30.2mg |
+0.7% |
99.95% |
Lab E |
| 25 Jul 2025 |
Tirzepatide |
6.3 |
30mg |
28.1mg |
-6.3% |
99.36% |
Lab E |